Piper Sandler raised the firm’s price target on CVS Health to $94 from $93 and keeps an Overweight rating on the shares. The firm continues to be hopeful, vs. confident, in CVS’s CY24 medical loss ratio guidance, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CVS:
